AN2 Therapeutics

AN2 Therapeutics is a biopharmaceutical company developing novel boron-based therapeutic compounds targeting rare, chronic, and serious infectious diseases, as well as hematology and oncology applications. The company has a pipeline of drug candidates including epetraborole and AN2-502998 that are in clinical development.